Publications by authors named "Christy Pifer"
Article Synopsis
- MSCs can effectively target low oxygen areas and release factors that promote blood vessel formation, benefiting ischemic conditions.
- In severe or chronic cases, combining stem cell therapy with angiogenic factors, specifically engineered to produce VEGF, offers stronger treatment potential.
- The MSC/VEGF therapy has shown promise in enhancing blood flow in animal models and has been safely developed with plans for clinical delivery in facilities lacking cell processing capabilities.
Background: Renal artery duplex ultrasonography (RA-DUS) is commonly used for the evaluation and follow-up of renal artery atherosclerotic disease. In a complete study, renal artery flow is evaluated from the vessel origin to the intraparenchymal branches. The quality of RA-DUS is in part technologist-dependent, but many factors may affect the ability to complete a diagnostic examination.
View Article and Find Full Text PDF